Description:GC376 is a synthetic compound that has garnered attention primarily for its antiviral properties, particularly against coronaviruses. It is classified as a peptidomimetic compound, which means it mimics the structure of peptides but is not composed of amino acids. GC376 functions as a protease inhibitor, specifically targeting the main protease of coronaviruses, thereby disrupting their replication cycle. This mechanism of action makes it a candidate for therapeutic use in treating viral infections, including those caused by coronaviruses like SARS-CoV and MERS-CoV. The compound has shown promise in preclinical studies, demonstrating efficacy in inhibiting viral replication. Additionally, GC376 has been investigated for its potential use in veterinary medicine, particularly in treating feline infectious peritonitis (FIP), a serious viral disease in cats. Its chemical structure and properties contribute to its stability and bioavailability, making it a subject of ongoing research in the field of antiviral drug development.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![(βS)-α-羟基-β-[[(2S)-4-甲基-1-氧代-2-[[(苯基甲氧基)羰基]氨基]戊基]氨基]-2-氧代-3-吡咯烷丙烷磺酸钠盐](https://static.cymitquimica.com/products/IN/thumb/DA01K3ET.jpg)
